$GUTS News

Fractyl Health (GUTS) Stock Sees Fair Value Cut After Mixed Revita Analyst Reactions

Fractyl Health Sharpens Focus on Revita Following Positive Pivotal Results, Advancing Toward Planned FDA De Novo Submission in Post-GLP-1 Weight Maintenance

Fractyl Health Announces Heightened Focus On Advancing Revita Toward Potential FDA Marketing Authorization And Commercialization In Post-GLP-1 Weight Maintenance

Canaccord Genuity Maintains Buy on Fractyl Health, Lowers Price Target to $39

Morgan Stanley Maintains Equal-Weight on Fractyl Health, Lowers Price Target to $4

Fractyl Health, Inc. (GUTS) Discusses Positive Top Line 6-Month Results From REMAIN-1 Study of Revita in Post GLP-1 Weight Maintenance Transcript

Fractyl Health Meets Six-Month Primary Endpoint in Revita Obesity Trial, Supporting FDA Submission Plans

Fractyl Health, Inc. (GUTS) Discusses Positive Top Line 6-Month Results From REMAIN-1 Study of Revita in Post GLP-1 Weight Maintenance - Slideshow

Fractyl Health's Revita Meets Six-Month Co-Primary Endpoint in Ongoing REMAIN-1 Pivotal Study, With Highly Statistically Significant Reduction in Weight Regain After GLP-1 Discontinuation

Why Fractyl Health Stock Is Sinking Friday

Fractyl Health’s REMAIN-1 Study Meets Six-Month Co-Primary Endpoint With High Statistical Significance; Demonstrates 80% Retention Of GLP-1 Induced Weight Loss Vs 67% For Sham

Fractyl Health, Inc. (GUTS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Fractyl Health to Participate in Upcoming September Investor Conferences

Fractyl Health, Inc. (GUTS) Discusses Commercialization Strategy for Investigational Post-GLP-1 Procedural Therapy Transcript

Fractyl Health shares rise 2.8% ahead of Virtual Commercial Strategy Day

Fractyl Health to Host Virtual Commercial Strategy Day on Tuesday, September 1, 2026: The Potential Path to Commercializing Revita®, a Procedural Therapy for Post-GLP-1 Weight Maintenance

Fractyl Health Eyes Q4 Revita Data, Launches Rejuva Gene Therapy Trial

Fractyl Health, Inc. Common Stock Q2 2026 Earnings Call Summary

Fractyl Health Inc (GUTS) (Q2 2026) Earnings Call Highlights: Pivotal Data on Track and ...

Fractyl Health, Inc. (GUTS) Q2 2026 Earnings Call Transcript